A branched-chain organic acid linked to multiple sclerosis: first identification by NMR spectroscopy of CSF.

(1)H NMR spectroscopy of cerebrospinal fluid (CSF) is currently being used to study metabolic profiles characteristic of distinct multiple sclerosis (MS) manifestations. For select MS patient groups, we have previously detected significantly increased concentrations of several identified metabolites and one unidentified compound. We now present, for the first time, the identification of the latter molecule, beta-hydroxyisobutyrate (BHIB). A combination of dedicated 1D and 2D (1)H NMR experiments was employed for signal assignment. To our knowledge, BHIB has not previously been identified in (1)H NMR spectra of biofluids or biological tissues. Our assignment suggests new biochemical pathways involved in specific MS pathologies.

[1]  M. Sasaki,et al.  3-Hydroxyisobutyric aciduria in two brothers. , 1998, Pediatric neurology.

[2]  W. Nyhan,et al.  Quantitative analysis for organic acids in biological samples: batch isolation followed by gas chromatographic-mass spectrometric analysis. , 1989, Clinical chemistry.

[3]  J. Vion-Dury,et al.  Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy. , 1998, Brain research. Brain research protocols.

[4]  M. Sasaki,et al.  A severely brain-damaged case of 3-hydroxyisobutyric aciduria , 2001, Brain and Development.

[5]  W. Brück,et al.  The spectrum of multiple sclerosis: new lessons from pathology , 2005, Current Opinion in Neurology.

[6]  M. Baumgartner,et al.  Clinical, biochemical, and molecular findings in three patients with 3-hydroxyisobutyric aciduria. , 2006, Molecular genetics and metabolism.

[7]  H. Hartung,et al.  Organic acids in cerebrospinal fluid and plasma of patients withl-2-hydroxyglutaric aciduria , 1995, Journal of Inherited Metabolic Disease.

[8]  P. Cozzone,et al.  Further assignment of resonances in 1H NMR spectra of cerebrospinal fluid (CSF) , 1998, FEBS letters.

[9]  M. Sasaki,et al.  Basal ganglia lesions in a patient with 3-hydroxyisobutyric aciduria , 2006, Brain and Development.

[10]  K. Gibson,et al.  Secondary inhibition of multiple NAD-requiring dehydrogenases in respiratory chain complex I deficiency: Possible metabolic markers for the primary defect , 1993, Journal of Inherited Metabolic Disease.

[11]  R. Harris,et al.  Purification and characterization of 3-hydroxyisobutyrate dehydrogenase from rabbit liver. , 1988, The Journal of biological chemistry.

[12]  J. Vion-Dury,et al.  Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy. , 1996, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[13]  D. Chitayat,et al.  Brain dysgenesis and congenital intracerebral calcification associated with 3-hydroxyisobutyric aciduria. , 1992, The Journal of pediatrics.

[14]  M. Brosnan,et al.  Valine metabolism. Gluconeogenesis from 3-hydroxyisobutyrate. , 1986, The Biochemical journal.

[15]  E. Davis,et al.  Amino acid catabolism by perfused rat hindquarter. The metabolic fates of valine. , 1986, The Biochemical journal.